ITMI971628A0 - - Google Patents

Info

Publication number
ITMI971628A0
ITMI971628A0 ITMI971628A ITMI971628A ITMI971628A0 IT MI971628 A0 ITMI971628 A0 IT MI971628A0 IT MI971628 A ITMI971628 A IT MI971628A IT MI971628 A ITMI971628 A IT MI971628A IT MI971628 A0 ITMI971628 A0 IT MI971628A0
Authority
IT
Italy
Application number
ITMI971628A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/446,617 priority Critical patent/US6410782B1/en
Application filed filed Critical
Publication of ITMI971628A0 publication Critical patent/ITMI971628A0/it
Priority to IT97MI001628A priority patent/IT1293305B1/it
Priority to ES98939625T priority patent/ES2207853T3/es
Priority to PCT/EP1998/004238 priority patent/WO1999002539A1/en
Priority to IL13317298A priority patent/IL133172A/xx
Priority to CNB988069326A priority patent/CN1161363C/zh
Priority to AT98939625T priority patent/ATE251631T1/de
Priority to HU0004679A priority patent/HUP0004679A3/hu
Priority to AU88067/98A priority patent/AU8806798A/en
Priority to DK98939625T priority patent/DK0994884T3/da
Priority to EP98939625A priority patent/EP0994884B1/en
Priority to PT98939625T priority patent/PT994884E/pt
Priority to KR10-2000-7000135A priority patent/KR100396036B1/ko
Priority to DE69818823T priority patent/DE69818823T2/de
Priority to JP2000502060A priority patent/JP3681637B2/ja
Priority to CA002303210A priority patent/CA2303210A1/en
Priority to BR9810561-2A priority patent/BR9810561A/pt
Publication of ITMI971628A1 publication Critical patent/ITMI971628A1/it
Application granted granted Critical
Publication of IT1293305B1 publication Critical patent/IT1293305B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/5765Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
IT97MI001628A 1997-07-09 1997-07-09 Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi IT1293305B1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
US09/446,617 US6410782B1 (en) 1997-07-09 1997-07-08 Diphosphonic acid salts for the treatment of osteoporosis
IT97MI001628A IT1293305B1 (it) 1997-07-09 1997-07-09 Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi
AU88067/98A AU8806798A (en) 1997-07-09 1998-07-08 Diphosphonic acid salts for the treatment of osteoporosis
PT98939625T PT994884E (pt) 1997-07-09 1998-07-08 Sais de acido difosfonico para o tratamento da osteoporose
IL13317298A IL133172A (en) 1997-07-09 1998-07-08 Diphosphonic acid salts for the treatment of osteoporosis
CNB988069326A CN1161363C (zh) 1997-07-09 1998-07-08 用于治疗骨质疏松症的双膦酸盐
AT98939625T ATE251631T1 (de) 1997-07-09 1998-07-08 Dipohosphonsäuresalze für die behandlung von osteoporose
HU0004679A HUP0004679A3 (en) 1997-07-09 1998-07-08 Diphosphonic acid-aminoalcohol salts and medicines containing the same
ES98939625T ES2207853T3 (es) 1997-07-09 1998-07-08 Sales de acido difosfonico para el tratamiento de la osteoporosis.
DK98939625T DK0994884T3 (da) 1997-07-09 1998-07-08 Diphosphonsyresalte til behandling af osteoporose
EP98939625A EP0994884B1 (en) 1997-07-09 1998-07-08 Diphosphonic acid salts for the treatment of osteoporosis
PCT/EP1998/004238 WO1999002539A1 (en) 1997-07-09 1998-07-08 Diphosphonic acid salts for the treatment of osteoporosis
KR10-2000-7000135A KR100396036B1 (ko) 1997-07-09 1998-07-08 골다공증 치료를 위한 디포스폰산 염
DE69818823T DE69818823T2 (de) 1997-07-09 1998-07-08 Dipohosphonsäuresalze für die behandlung von osteoporose
JP2000502060A JP3681637B2 (ja) 1997-07-09 1998-07-08 骨粗鬆症の治療用のジホスホン酸塩
CA002303210A CA2303210A1 (en) 1997-07-09 1998-07-08 Salts of diphosphonic acids and amino-alcohols for the treatment of osteoporosis
BR9810561-2A BR9810561A (pt) 1997-07-09 1998-07-08 Difosfonatos ou sais de ácidos difosfÈnicos e derivados de amino-álcoois aromáticos, processo para preparação de difosfonatos, uso de difosfonatos ou seus sais, e, composições farmacêuticas para o tratamento de osteoporose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001628A IT1293305B1 (it) 1997-07-09 1997-07-09 Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi

Publications (3)

Publication Number Publication Date
ITMI971628A0 true ITMI971628A0 (US06559137-20030506-C00166.png) 1997-07-09
ITMI971628A1 ITMI971628A1 (it) 1999-01-09
IT1293305B1 IT1293305B1 (it) 1999-02-16

Family

ID=11377528

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI001628A IT1293305B1 (it) 1997-07-09 1997-07-09 Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi

Country Status (17)

Country Link
US (1) US6410782B1 (US06559137-20030506-C00166.png)
EP (1) EP0994884B1 (US06559137-20030506-C00166.png)
JP (1) JP3681637B2 (US06559137-20030506-C00166.png)
KR (1) KR100396036B1 (US06559137-20030506-C00166.png)
CN (1) CN1161363C (US06559137-20030506-C00166.png)
AT (1) ATE251631T1 (US06559137-20030506-C00166.png)
AU (1) AU8806798A (US06559137-20030506-C00166.png)
BR (1) BR9810561A (US06559137-20030506-C00166.png)
CA (1) CA2303210A1 (US06559137-20030506-C00166.png)
DE (1) DE69818823T2 (US06559137-20030506-C00166.png)
DK (1) DK0994884T3 (US06559137-20030506-C00166.png)
ES (1) ES2207853T3 (US06559137-20030506-C00166.png)
HU (1) HUP0004679A3 (US06559137-20030506-C00166.png)
IL (1) IL133172A (US06559137-20030506-C00166.png)
IT (1) IT1293305B1 (US06559137-20030506-C00166.png)
PT (1) PT994884E (US06559137-20030506-C00166.png)
WO (1) WO1999002539A1 (US06559137-20030506-C00166.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
EA200601630A1 (ru) * 2004-03-04 2007-02-27 Макото Юаса Ниосома, имеющая внедрённый в неё маталлопорфириновый комплекс, способ её получения и лекарственное средство с её использованием
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
FR2926081B1 (fr) * 2008-01-03 2010-02-19 Univ Nantes Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux
EP2266578A4 (de) * 2008-03-18 2011-08-17 Dikovskiy Aleksander Vladimirovich Pharmazeutische zusammensetzung zur prävention und behandlung von knochenresorption unterschiedlicher ätiologie
KR20110079813A (ko) * 2008-09-22 2011-07-08 아이시스 이노베이션 리미티드 이미다조〔1,2-α〕피리디닐 비스포스포네이트
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
EP3084483A1 (en) * 2013-12-19 2016-10-26 3M Innovative Properties Company Articles comprising self-assembled layers comprising nanoparticles with a phosphorous surface treatment
CN106361701B (zh) * 2016-08-31 2019-08-27 上海交通大学 一种脂质体药物载体及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751372A (en) 1971-06-18 1973-08-07 Hercules Inc Scale and corrosion control in circulating water using polyphosphates and organophonic acids
GB1508772A (en) 1975-04-04 1978-04-26 Shell Int Research Biologically active compositions
DD150744A1 (de) 1980-04-02 1981-09-16 Sigurd Wobst Verfahren zur kontinuierlichen herstellung von cycloalkylhydroperoxiden
IT1201087B (it) 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
DE3434667A1 (de) * 1984-09-21 1986-04-03 Henkel KGaA, 4000 Düsseldorf 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
JPS63165457A (ja) 1986-12-27 1988-07-08 Lion Corp 導電性樹脂組成物
JPS63286478A (ja) 1987-05-19 1988-11-24 Lion Corp 導電性塗料組成物
DD273650A1 (de) 1988-07-01 1989-11-22 Robotron Elektronik Verfahren zur chemischen anschlagvernicklung von kupferstrukturen auf dielektrika
SK10193A3 (en) 1990-07-13 1993-10-06 Procter & Gamble Anticalculus antiplaque compositions using azacycloalkane diphosphonates
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
CA2077312C (en) * 1992-09-01 2000-02-08 Ronald L. Oleka Condensate polisher regenerant system
JPH06100576A (ja) * 1992-09-21 1994-04-12 Kirin Brewery Co Ltd 骨粗鬆症治療剤または予防剤
JP3238304B2 (ja) * 1995-08-11 2001-12-10 三菱重工業株式会社 スケール溶解液
JP3445426B2 (ja) 1995-12-26 2003-09-08 花王株式会社 高吸水性樹脂組成物

Also Published As

Publication number Publication date
JP2001509510A (ja) 2001-07-24
KR100396036B1 (ko) 2003-08-27
CN1261892A (zh) 2000-08-02
EP0994884A1 (en) 2000-04-26
HUP0004679A2 (hu) 2001-08-28
BR9810561A (pt) 2000-08-15
PT994884E (pt) 2004-02-27
CA2303210A1 (en) 1999-01-21
WO1999002539A1 (en) 1999-01-21
AU8806798A (en) 1999-02-08
EP0994884B1 (en) 2003-10-08
DK0994884T3 (da) 2004-02-16
JP3681637B2 (ja) 2005-08-10
HUP0004679A3 (en) 2002-04-29
US6410782B1 (en) 2002-06-25
DE69818823T2 (de) 2004-05-06
IL133172A (en) 2005-03-20
IL133172A0 (en) 2001-03-19
CN1161363C (zh) 2004-08-11
ES2207853T3 (es) 2004-06-01
IT1293305B1 (it) 1999-02-16
KR20010021577A (ko) 2001-03-15
ATE251631T1 (de) 2003-10-15
DE69818823D1 (de) 2003-11-13
ITMI971628A1 (it) 1999-01-09

Similar Documents

Publication Publication Date Title
BE2018C032I2 (US06559137-20030506-C00166.png)
IN190784B (US06559137-20030506-C00166.png)
CH0944937H2 (US06559137-20030506-C00166.png)
ITVE970018A0 (US06559137-20030506-C00166.png)
ITMI971628A0 (US06559137-20030506-C00166.png)
ITMI971500A0 (US06559137-20030506-C00166.png)
BE2013C047I2 (US06559137-20030506-C00166.png)
IN184842B (US06559137-20030506-C00166.png)
IN189805B (US06559137-20030506-C00166.png)
IN189575B (US06559137-20030506-C00166.png)
IN190488B (US06559137-20030506-C00166.png)
BR9701757A (US06559137-20030506-C00166.png)
IN191989B (US06559137-20030506-C00166.png)
IN192213B (US06559137-20030506-C00166.png)
ITAL970007V0 (US06559137-20030506-C00166.png)
ITTV970023V0 (US06559137-20030506-C00166.png)
ITTP970005A0 (US06559137-20030506-C00166.png)
BR9700653A (US06559137-20030506-C00166.png)
GB9724190D0 (US06559137-20030506-C00166.png)
ITUD970073A0 (US06559137-20030506-C00166.png)
CN3054099S (US06559137-20030506-C00166.png)
CN3059079S (US06559137-20030506-C00166.png)
CN3054902S (US06559137-20030506-C00166.png)
CN3055179S (US06559137-20030506-C00166.png)
CN3054556S (US06559137-20030506-C00166.png)

Legal Events

Date Code Title Description
0001 Granted